BASSAGANYA-RIERA JOSEP (Chairman, President and CEO) reported 2 transactions at LANDOS BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/9/2022ACC: 0001843575-22-000003
DirectorOfficer10% Owner· Chairman, President and CEO
Since Feb 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
500K acquired · 500K disposed
Non-Derivative Transactions2
common stock
Indirect
Shares
−500K
Price / share
—
Trade value
—
% of position
12.5%
8/5/2022
3.99M→3.49M
common stock
Indirect
Shares
+500K
Price / share
—
Trade value
—
% of position
New position
8/5/2022
0.00→500K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Indirect | 8/5/2022 | G · Gift | −500K | — | — | 12.5% | 3.99M | 3.49M |
| common stock Indirect | 8/5/2022 | G · Gift | +500K | — | — | New position | 0.00 | 500K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
common stock
IndirectShares owned766.40K
common stock
IndirectShares owned786.30K
common stock
IndirectShares owned823.96K
Total
2.38M indirect2.38M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| common stock | 766.40K | Indirect |
| common stock | 786.30K | Indirect |
| common stock | 823.96K | Indirect |
| Total | 2.38M | 2.38M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported